defa14a
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant
þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
Preliminary Proxy Statement |
o |
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
o |
Definitive Proxy Statement |
þ |
Definitive Additional Materials |
o |
Soliciting Material Pursuant to Rule 14a-12 |
BEVERLY ENTERPRISES, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ |
No fee required. |
o |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
(1) |
Title of each class of securities to which transaction applies:
|
|
|
(2) |
Aggregate number of securities to which transaction applies:
|
|
|
(3) |
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
|
|
|
(4) |
Proposed maximum aggregate value of transaction:
|
|
|
(5) |
Total fee paid:
|
o |
Fee paid previously with preliminary materials. |
|
o |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
|
(1) |
Amount Previously Paid:
|
|
|
(2) |
Form, Schedule or Registration Statement No.:
|
|
|
(3) |
Filing Party:
|
|
|
(4) |
Date Filed:
|
|
|
|
|
|
William R. Floyd
Chairman, President and Chief Executive Officer
March 15, 2005 |
To Our Stockholders and Associates:
Many of you will notice a new corporate identification on this
annual letter to you. This change reflects the success
weve achieved both over the course of 2004 and
the previous three years in repositioning your
company as a strong leader in innovative clinical services and
value-added patient care across the long-term care spectrum.
BEIs industry leadership and bright prospects contrast
sharply with our position four years ago, when the company was
in an extremely weak financial condition with nearly
$1 billion in debt and a cash balance of only
$26 million and experiencing inconsistent
operational performance and low morale across the organization.
The troubled circumstances of the past make us all the more
proud of our strong performance since then. In 2004 we completed
the turnaround of our financial and operating results, and we
have simultaneously built a solid foundation for profitable
growth. Across the company our morale is higher than ever, and
we are united in our confidence that this profitable growth will
continue into the future.
Over the past four years, we have effectively executed on a
strategic plan to generate significantly enhanced value for
stockholders, based on the following key initiatives:
|
|
|
|
|
Strengthening and growing our skilled nursing portfolio; |
|
|
|
Accelerating the growth of our service businesses; |
|
|
|
Establishing a leadership position in eldercare
innovation; and |
|
|
|
Continually re-engineering our company for greater effectiveness. |
Solid Financial and Operating Improvements in 2004
Our financial and operating results for the year clearly
demonstrate that our strategic plan is working, and underscore
our belief that the fruits of that plan and its
growth initiatives are just beginning to be
recognized by the financial markets.
Net income from continuing operations rose 54 percent on a
10 percent increase in revenues, compared to 2003.
Earnings before interest, taxes, depreciation and amortization
(EBITDA)* totaled
$191 million, an increase of 22 percent from the prior
year. Our EBITDA margin rose 92 basis points to an average
of
9.6 percent.**
Cash flow from operations totaled nearly $76 million in
2004. This amount was impacted by approximately $82 million
when Beverly Funding Corporation paid off the last of our
off-balance sheet financings and was reconsolidated on our
balance sheet. Excluding this impact, our cash flow from
operations would have totaled $158 million, an increase of
126 percent over 2003 levels.
Our investments in capital expenditures to fuel further growth
totaled $63 million in 2004, up more than 40 percent
from the prior year.
Strengthened Financial Position
As evidenced by these highlights, we have made great strides in
simultaneously reducing the overall level of our companys
debt, while also strengthening our balance sheet in other key
areas. I am pleased to say that we have reduced the
companys debt by 43 percent, from its peak of nearly
$1 billion at the end of 2000, to $558 million at
year-end 2004.
At the same time, we have significantly strengthened our balance
sheet by increasing our cash balance nearly ten-fold to a total
of $216 million at year-end 2004, extending debt maturities
and reducing interest expense during 2004 by 28 percent,
compared to 2003.
In particular, our balance sheet was bolstered considerably
through two major refinancings of our debt, the most recent of
which was successfully completed this past year when we made a
tender offer for $200 million of our
95/8 percent
senior notes due in 2009. These notes were replaced with
77/8 percent
senior subordinated notes due in 2014. The refinancings alone
have extended our debt maturities by eight years, and reduced
our annualized interest expense by $13 million.
All of this adds up to significantly increased flexibility and
enhanced resources that can be deployed to build stockholder
value. Our strengthened financial position has become, in
effect, a powerful engine for growth that enables us to continue
to invest for the future across all of our businesses, while
maintaining a comfortable cash balance.
Stronger Portfolio Of Skilled Nursing Facilities
2004 was a year of strong achievement and fresh beginnings for
our skilled nursing facilities business. We substantially
completed our divestiture program, eliminating during the past
two years 112 facilities that were chronic underperformers, were
responsible for a disproportionately high share of patient
liability costs or simply were not a good strategic fit with the
rest of our portfolio.
Today, our portfolio of skilled nursing facilities is
concentrated in 23 states and the District of Columbia.
Building on this strong portfolio, we intend to fuel our
companys profitable growth through a number of
initiatives. First, we intend to broaden the range of products
and services we provide within these facilities, consistent with
emerging long-term care and demographic trends, such as
expanding the specialized Alzheimers care units that we
already have in more than 100 facilities across a wide segment
of our portfolio. Second, we plan to expand our business base by
adding new facilities and bed capacity, both through organic
growth and acquisitions in targeted markets. And, third we are
targeting increased Medicare revenues and a stronger Medicaid
business base in a careful and strategic fashion.
Increasing Growth Potential By Profitably Building Our
Services Businesses
Our skilled nursing facilities business is not only highly
attractive on its own, but also in terms of the synergies it
provides for our higher-margin services businesses, particularly
in contract rehabilitation therapy and hospice care. These are
underserved and fragmented multi-billion dollar eldercare
markets that are growing significantly each year due to a
combination of demographic and long-term care industry trends.
Aegis Therapies and AseraCare Hospice our
rehabilitation and hospice care units, respectively
leverage the infrastructure and management organization of our
skilled nursing facilities, providing a cost-efficient and
low-risk entry point for us into these markets. Our skilled
nursing facilities have given us a clear edge in successfully
managing operations and associates to serve an expanding client
base at multiple locations across the country.
We have dramatically expanded this initial client base at both
Aegis and AseraCare. For 2004, our service businesses
represented approximately 10 percent of BEIs revenue,
and nearly 30 percent of the companys pre-tax income.
An important event in expanding and developing our service
businesses was the July 2004 acquisition of Hospice USA by
AseraCare Hospice. This acquisition doubled the size of our
hospice operations and significantly accelerated our growth and
profit potential, making us a major player in this increasingly
important eldercare service field. Our strong financial position
enabled us to complete this acquisition on an all-cash basis,
making this transaction accretive in the first year.
Aegis continued its aggressive growth throughout 2004, with
third-party revenues up 58 percent from the prior year.
This reflects higher revenues from existing clients, as well as
expansion of its overall business base, which currently includes
nearly 600 non-BEI clients. Aegis maintains EBITDA margins in
the mid-teens more than twice the average of other
major therapy providers.
We remain on-target to continue expanding and developing these
highly attractive service businesses which, combined
with our core nursing home operations, create a stronger and
more valuable company for our clients, patients and stockholders.
* * *
In summary, the positive momentum we have been building over the
past several years has intensified, as measured by virtually
every financial and operational performance metric. As we have
transformed our company, we have never lost sight of the shared
values and guiding principles responsible for our success:
Quality care and superior service for our clients, patients and
their families. All of our profitable growth initiatives have
their roots in both eldercare innovation and continuous
operational improvement.
We are learning, however, that success can have its price. A
group of opportunistic investors has launched a proxy contest in
an effort to seize control of BEIs Board of Directors and
force the company to pursue what would be, in our view, a
transaction that is not in the best interests of all
stockholders, as well as our clients, patients, associates and
the communities of which we are an integral part.
You should rest assured that their actions will not deter us
from continuing to develop our businesses in the best interests
of all stockholders. We have a proven Board of Directors and a
seasoned management team that is successfully executing a clear
strategic plan, with specific growth initiatives that are paving
the way towards increasingly higher returns for stockholders.
We are working hard every day to maintain the confidence and
trust of all of our stockholders. On behalf of our Board and
senior management team, I would like to express our thanks to
our stockholders and associates for their support throughout
2004. We look forward to an even more successful 2005.
|
|
|
Sincerely, |
|
|
|
|
|
William R. Floyd |
Important Information
On March 15, 2005, Beverly Enterprises, Inc.
(BEI) filed a definitive proxy statement with the
Securities and Exchange Commission relating to BEIs
solicitation of proxies with respect to its 2005 annual meeting
of stockholders. BEI URGES INVESTORS AND SECURITY HOLDERS TO
READ THE PROXY STATEMENT BECAUSE IT CONTAINS IMPORTANT
INFORMATION. You may obtain BEIs proxy statement, any
amendments or supplements to the proxy statement and other
relevant documents free of charge at www.sec.gov or at
www.beverlycorp.com under the tab Investor
Information and then under the heading SEC
Filings. You may also obtain a free copy of BEIs
proxy statement, any amendments and supplements to the proxy
statement and other relevant documents by writing to Beverly
Enterprises, Inc. at One Thousand Beverly Way, Fort Smith,
Arkansas 72919, Attn: Investor Relations.
Information Regarding Participants
Information regarding the names, affiliation and interests of
individuals who may be deemed participants in the solicitation
of proxies for BEIs 2005 annual meeting of stockholders is
contained in the definitive proxy statement filed by BEI with
the Securities and Exchange Commission on March 15, 2005.
Forward-Looking Statements
The statements in this document relating to matters that are not
historical facts are forward-looking statements based on
managements beliefs and assumptions using currently
available information and expectations as of the date hereof.
Forward-looking statements are not guarantees of future
performance and involve certain risks and uncertainties,
including the risks and uncertainties detailed from time to time
in BEIs filings with the Securities and Exchange
Commission. In addition, our results of operations, financial
condition and cash flows also may be adversely impacted by the
unsolicited indication of interest in an acquisition of BEI by
Arnold Whitman, Formation Capital, LLC, Appaloosa Management,
LP, Franklin Mutual Advisors, LLC and Northbrook NBV, LLC, and
related actions taken by this group, including the nomination of
candidates for election to BEIs board of directors. These
actions may impact our ability to attract and retain customers,
management and employees and may result in the incurrence of
significant advisory fees, litigation costs and other expenses.
Although BEI believes that the expectations reflected in such
forward-looking statements are reasonable, it cannot give any
assurances that these expectations will prove to be correct. BEI
assumes no duty to publicly update or revise such statements,
whether as a result of new information, future events or
otherwise.
BEI Board of Directors and Executive Officers
Board of Directors
|
|
|
William R. Floyd
Chairman of the Board, President
Chief Executive Officer and Director
Melanie Creagan Dreher, Ph.D.
Kelting Dean
University of Iowa College of Nursing
John D. Fowler, Jr.
Vice Chairman
Deutsche Bank Securities, Inc.
John P. Howe, III, M.D.
President and Chief Executive Officer
Project Hope
James W. McLane
Director
Healthaxis Inc.
Ivan R. Sabel
Chairman of the Board and Chief Executive Officer
Hanger Orthopedic Group, Inc.
Donald L. Seeley
Director, Applied Investment Management Program
University of Arizona Department of Finance
Marilyn R. Seymann, Ph.D.
President and Chief Executive Officer
M One, Inc.
Executive Officers
William R. Floyd
Chairman of the Board, President, Chief Executive Officer and
Director
Douglas J. Babb
Executive Vice President and Chief Administrative and Legal
Officer
David R. Devereaux
Executive Vice President and Chief Operating Officer
Nursing Facilities |
|
Jeffrey P. Freimark
Executive Vice President, Chief Financial and Information
Officer
Cindy H. Susienka
Executive Vice President and Chief Operating Officer
Aegis and AseraCare
Patrice K. Acosta
Senior Vice President Quality of Life Programs
Pamela H. Daniels
Senior Vice President, Controller and Chief Accounting
Officer
Lawrence Deans
Senior Vice President Human Resources
James M. Griffith
Senior Vice President Investor Relations and
Corporate Communications
Patricia C. Kolling
Senior Vice President Compliance
Andrea J. Ludington
Senior Vice President Professional Services
Barbara R. Paul, M.D.
Senior Vice President and Chief Medical Officer
Harold A. Price, Ph.D.
Senior Vice President Sales and Business
Development
Chris W. Roussos
President AseraCare
Martha J. Schram
President Aegis Therapies
Richard D. Skelly, Jr.
Senior Vice President and Treasurer
Jane A. Washburn
Senior Vice President and Chief Marketing Officer |
|
|
|
|
Transfer Agent and Registrar
At March 7, 2005, there were 4,838 record holders of
BEIs common stock. The Bank of New York acts as the
Companys transfer agent and registrar, and maintains all
stockholder records. Inquiries related to stockholder records,
stock transfers, change in ownership and changes of address
should be sent to the transfer agent at the following
address:
The Bank of New York
Shareholder Relations Department
Church Street Station, 11E
P.O. Box 11258
New York, NY 10286
E-mail: shareowners-svcs@bankofny.com
Phone: (800) 524-4458
Web site: http://www.stockbny.com |
|
Stockholder Information and Services
BEI common stock is listed and traded on the New York Stock
Exchange and the Pacific Exchange under the ticker symbol BEV.
Complimentary copies of reports filed with the Securities and
Exchange Commission, as well as quarterly earnings
announcements, are available from:
Beverly Enterprises, Inc.
Investor Relations
One Thousand Beverly Way
Fort Smith, AR 72919
Phone: (479) 201-2000
These materials also are available on the Companys
website: www.beverlycorp.com |
|
|
* |
We define EBITDA as earnings from continuing operations before
interest expense (including costs related to early
extinguishments of debt), interest income, income taxes,
depreciation and amortization. The BEI Board looks to EBITDA in
considering managements performance because EBITDA is
commonly used by our lenders and investors to assess our
leverage capacity, debt service ability and liquidity, and we
use EBITDA to evaluate financial performance and to design
incentive compensation for management. EBITDA is not considered
a measure of financial performance under U.S. generally accepted
accounting principles (GAAP), and the items excluded
from EBITDA are significant components in understanding and
assessing our financial performance. EBITDA should not be
considered as an alternative to net income, cash flows provided
by or used in operating, investing or financing activities or
other financial statement data presented in our consolidated
financial statements as an indicator of financial performance or
liquidity. Since EBITDA is not a measure determined in
accordance with GAAP and is thus susceptible to varying
calculations, EBITDA, as presented, may not be comparable to
other similarly titled measures of other companies. |
|
|
|
EBITDA has limitations as an analytical tool, and you should not
consider it in isolation or as a substitute for analysis of our
results as reported under GAAP. Some of these limitations are: |
|
|
|
|
|
EBITDA does not reflect our cash expenditures, or future
requirements, for capital expenditures or contractual
commitments; |
|
|
|
EBITDA does not reflect changes in, or cash requirements for,
our working capital needs; |
|
|
|
EBITDA does not reflect interest expense, or the cash
requirements necessary to service interest or principal
payments, on our debt; and |
|
|
|
although depreciation and amortization are non-cash charges, the
assets being depreciated and amortized will often have to be
replaced in the future, and EBITDA does not reflect any cash
requirements for such replacements. |
|
|
|
Because of these limitations, EBITDA should not be considered as
a measure of discretionary cash available to us to invest in the
growth of our business. We compensate for these limitations by
relying primarily on our GAAP results and using EBITDA only
supplementally. |
|
|
** |
The following table provides a reconciliation from our pre-tax
income (loss) from continuing operations, which is the most
directly comparable financial measure presented in accordance
with GAAP for the periods indicated: |
Beverly Enterprises, Inc.
2004 and 2003 Continuing Operations EBITDA
Reconciliation
|
|
|
|
|
|
|
|
|
|
|
December 31, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Revenues
|
|
$ |
1,988.9 |
|
|
$ |
1,802.0 |
|
EBITDA
|
|
|
190.8 |
|
|
|
156.2 |
|
Depreciation and amortization
|
|
|
62.2 |
|
|
|
58.8 |
|
Costs related to early extinguishments of debt
|
|
|
40.9 |
|
|
|
6.6 |
|
Interest expense, net
|
|
|
40.2 |
|
|
|
58.0 |
|
|
|
|
|
|
|
|
Pre-tax income
|
|
$ |
47.6 |
|
|
$ |
32.8 |
|
|
|
|
|
|
|
|